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Abstract. The progesterone receptor (PR) mediates progesterone regulation of female 
reproductive physiology, as well as gene transcription in non-reproductive tissues, such as brain, 
bone, lung and vasculature, in both women and men.  An unusual property of progesterone is its 
high affinity for the mineralocorticoid receptor (MR), which regulates electrolyte transport in the 
kidney in humans and other terrestrial vertebrates.  In humans, rats, alligators and frogs, 
progesterone antagonizes activation of the MR by aldosterone, the physiological 
mineralocorticoid in terrestrial vertebrates.  In contrast, in elephant shark, ray-finned fishes and 
chickens, progesterone activates the MR.  Interestingly, cartilaginous fishes and ray-finned fishes 
do not synthesize aldosterone, raising the question of which steroid(s) activate the MR in 
cartilaginous fishes and ray-finned fishes.  The simpler synthesis of progesterone, compared to 
cortisol and other corticosteroids, makes progesterone a candidate physiological activator of the 
MR in elephant sharks and ray-finned fishes.  Elephant shark and ray-finned fish MRs are 
expressed in diverse tissues, including heart, brain and lung, as well as, ovary and testis, two 
reproductive tissues that are targets for progesterone, which together suggests a multi-faceted 
physiological role for progesterone activation of the MR in elephant shark and ray-finned fish.  
The functional consequences of progesterone as an antagonist of some terrestrial vertebrate MRs 
and as an agonist of fish and chicken MRs are not fully understood.  Indeed, little is known of 
physiological activities of progesterone via any vertebrate MR. 
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Introduction.  The progesterone receptor (PR) and mineralocorticoid receptor (MR) are steroid 
receptors that belong to the nuclear receptor family, a diverse group of transcription factors that 
also includes the estrogen receptor (ER), androgen receptor (AR), and glucocorticoid receptor 
(GR) [1-5].  In humans and other terrestrial vertebrates, the PR and MR mediate the 
physiological actions of progesterone and aldosterone, respectively (Figure 1).  Although 
aldosterone is the main physiological mineralocorticoid in terrestrial vertebrates, diverse 
corticosteroids including cortisol, corticosterone and 11-deoxycorticosterone also are ligands for 
vertebrate MRs [6-8]. 
 
Figure 1. Structures of Progesterone, Adrenal Steroids and Spironolactone.  
Aldosterone and 11-deoxycorticosterone are the main physiological mineralocorticoids in 
vertebrates.  Cortisol and corticosterone are the main physiological glucocorticoids in 
vertebrates.  Progesterone, a female reproductive steroid, and spironolactone are antagonists for 
human MR [9, 10] and agonists for fish MRs [11-16] and chicken MR [12, 13]. 
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Progesterone and aldosterone have different functions in vertebrates.  Progesterone is 
considered to be a female reproductive steroid due to its regulation of gene expression in 
mammary gland and uterus, which affects many aspects of female reproductive physiology, 
including fertilization, maintenance of pregnancy and preparation of the endometrium for 
implantation and parturition [17-20].  However, progesterone also has important physiological 
actions in males including in prostate and testes [21-24].  Moreover, progesterone activates the 
PR in the brain, bone, thymus, lung and vasculature in females and males [25, 26].  Thus, 
progesterone is a steroid with diverse physiological activities in many organs in females and 
males. 
Aldosterone is the physiological mineralocorticoid in terrestrial vertebrates.  Aldosterone 
activates the MR in the distal tubule of the kidney to retain sodium and regulate blood pressure 
and secret potassium [7, 27-32].  In addition to this classical function, aldosterone activation of 
the MR regulates electrolyte transport across other epithelial tissues, including colon, salivary 
and sweat glands and airway epithelia of the lung [29, 33-35].  Moreover, aldosterone activates 
the MR in nonepithelial tissues, including brain, heart, ovaries, pancreas, adipocytes [6, 33, 35-
41].  Thus, like the PR, the MR is active in many organs with diverse physiological activities. 
 
Low concentrations of aldosterone and progesterone activate their receptors 
At concentrations below 1 nM, aldosterone and progesterone are transcriptional 
activators of the MR and PR, respectively.  The half-maximal response (EC50) for 
transcriptional activation by aldosterone of human MR is about 0.1 nM [9, 13, 16, 42, 43].  EC50 
values for transcriptional activation by progesterone of human PR are about 0.5 to 1 nM [44, 45].  
Based on the high affinity of aldosterone and progesterone for the MR and PR, each steroid 
would be expected to be specific for its cognate receptor.  Although this is true for aldosterone, 
which is specific for the MR, unexpectedly, as described below, progesterone has a high affinity 
for the MR. 
 
Progesterone: An unexpected high affinity antagonist for human MR 
Beginning in the 1950s, various in vivo studies found that, at nM concentrations, 
progesterone can antagonize aldosterone or 11-deoxycorticosterone activation of rat MR [46-48], 
human MR [49] and amphibian MR [50, 51].  These studies indicated that although progesterone 
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had a high affinity for the MR, progesterone was not a transcriptional activator of the MR.  
Because in vivo studies of binding and activation of the MR by corticosteroids and progesterone 
can be complicated by their binding to serum proteins [8], purified MR was needed for an 
accurate determination of the affinity of progesterone for human MR.  Purified MR became 
available with the cloning of the human MR by Arriza et al, [6].  Using recombinant human MR, 
Arriza et al reported that aldosterone, cortisol, corticosterone, 11-deoxycorticosterone, and 
progesterone had a similar nM affinity for human MR.  Further studies by Rupprecht et al. [10], 
Geller et al. [9] and Katsu et al. [13] showed that progesterone was a human MR antagonist with 
sub nM affinity. 
 
Progesterone is a transcriptional activator of ray-finned fish and chicken MRs 
In contrast to the antagonist activity of progesterone for human, rodent and amphibian 
MRs, progesterone is a transcriptional activator of several fish MRs, including trout [15], 
zebrafish [11, 13, 52], sturgeon and gar [16].  Progesterone also activates chicken MR [12, 13].  
Progesterone has EC50s of less than 1 nM for these MRs, which makes progesterone a potential 
physiological activator of these MRs. 
 
Progesterone is a transcriptional activator of elephant shark MR. 
The evidence that progesterone activates ray-finned fish MR, but not human MR raised 
the question of when did progesterone activation of ray-finned fish MRs evolve?  Did 
progesterone activation of the MR evolve in the ray-finned fish line, or did it evolve in a 
cartilaginous fish, which belong to a group of vertebrates that diverged from ray-finned fish and 
terrestrial vertebrates about 450 million years ago [1, 36, 53-56] (Figure 2).  To answer this 
question, we cloned elephant shark MR and studied its activation by progesterone, aldosterone 
and other corticosteroids [12].  We chose elephant shark MR because elephant shark occupies a 
key phylogenetic position in the evolution of ray-finned fish and terrestrial vertebrates [54, 56] 
(Figure 2).  Moreover, genomic analyses reveal that elephant shark has the slowest evolving 
genome of all known vertebrates [54], including the coelacanth, making elephant shark MR an 
attractive receptor to study early events in the evolution of mechanisms for regulating MR 
transcription. 
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Figure 2. Evolution of Mineralocorticoid, Glucocorticoid, Progesterone and Androgen 
Receptors. 
The corticoid receptor (CR) and PR are found in lampreys and hagfish, which are jawless fishes 
(cyclostomes) that evolved at the base of the vertebrate line.  A separate MR and GR first appear 
cartilaginous fish (Chondrichthyes), such as sharks, rays and skates.  The AR first appears in 
cartilaginous fishes. 
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We found that progesterone, as well as two related steroids, 19norProgesterone and 
spironolactone, are transcriptional activators of elephant shark MR [12], which we interpreted as 
indicating that progesterone was an ancestral activator of the MR and that progesterone 
activation of the MR was conserved in ray-finned fish [11-13, 15, 16, 52], lost in amphibians, 
alligators, rats and humans, and that progesterone activation of the MR evolved independently in 
chickens [12, 13]. 
 
Evolution of progesterone binding to the mineralocorticoid receptor. 
An insight into the evolution of progesterone binding to the MR comes from an analysis 
of the sequences of steroid receptors in jawless vertebrates (Cyclostomes: lampreys, hagfish) and 
cartilaginous fish (Chondrichthyes: sharks, rays, skates, chimaeras) [1, 36, 53-58] (Figure 2).  
Lampreys and hagfish contain a corticoid receptor (CR), which is related to both the PR and MR 
[1, 36, 55, 58].  Sequence analysis reveals that the CR and PR evolved from a common ancestor 
[1, 36, 55, 58] in an ancestral jawless vertebrate that has descendants in modern lampreys and 
hagfish [57, 59] (Figure 2).  The MR and its kin, the GR, first appear in cartilaginous fish [1, 36, 
55] (Figure 2).  The MR and the GR evolved through duplication and divergence of a CR [7, 28, 
36, 60].  Sequence analysis indicates that the MR is closer to the CR than is the GR [1, 36, 55, 
60].   
The CR in jawless vertebrates is activated by progesterone [55].  Progesterone activation 
of the CR is conserved in elephant shark MR, which is activated by nM concentrations of 
progesterone [12] (Figure 3).  Progesterone activation of elephant shark MR is conserved in ray-
finned fish MRs [11-13, 15, 16, 52].  However, progesterone activation of the MR was lost in 
amphibians, alligators, rodents and humans [9, 13], in which aldosterone is the physiological 
mineralocorticoid [28, 61]. 
As mentioned earlier, aldosterone has not been found in either cartilaginous fish or ray-
finned fish.  Aldosterone first appears in lungfish [62-64], which are forerunners of terrestrial 
vertebrates.  The evolution of aldosterone as the mineralocorticoid in amphibians, in which it 
regulates electrolyte homeostasis, has been proposed to be important in the conquest of land by 
terrestrial vertebrates [28, 65, 66] 
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Figure 3. Dependence of Activation by Progesterone of vertebrate MRs on the presence of 
either Leucine or Threonine in Helix 8. 
MRs with a key leucine in helix 8 are activated by progesterone.  With the exception of chicken 
MR, progesterone does not activate MRs containing a threonine in helix 8. 
 
 
Mutant human MR Thr870Leu is activated by progesterone. 
For over a decade, the molecular mechanism for progesterone acting as an MR agonist in 
ray-finned fish and an MR antagonist in mammals was unknown [36].  Recently, Fuller et al. 
[52] solved this riddle through a series of experiments in which they studied progesterone 
activation of chimeras of human and zebrafish MR, in which segments of their LBDs were 
exchanged to form human and zebrafish chimeras that were investigated for activation by 
progesterone.  These studies identified Leu856 in helix 8 in zebrafish MR as critical for 
progesterone activation of zebrafish MR (Figure 4).  Replacement of Leu856 with threonine, 
which is the corresponding amino acid in helix 8 in human MR, yielded zebrafish Thr856 MR, 
which was not activated by progesterone.  Importantly, replacement of Thr870 in human MR 
with leucine, yielded a mutant Leu870 MR that was activated by progesterone, as well as by 
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aldosterone.  These experiments confirmed the critical role of Thr870 in human MR in 
determining  progesterone antagonist activity and of Leu856 in zebrafish MR in regulating 
progesterone agonist activity [52].  Interestingly, in mouse and rat MR, a serine corresponds to 
Thr870 of human MR.  Substitution of serine for Leu856 in zebrafish MR results in the same 
loss of activation by spironolactone as found for substitution with threonine [52]. 
 
Figure 4. Alignment of Helix 8 in the MR in Human, Chicken, Xenopus, Lungfish, Elephant 
Shark and Zebrafish and CR in Lamprey and Hagfish. 
 
Analysis of MR sequences in other vertebrates revealed that elephant shark MR and ray-
finned fish MRs have a leucine corresponding the Leu856 in zebrafish MR, which explains their 
activation by progesterone [52].  Fuller et al. noted that Leu872 in lungfish MR (Figure 4) 
corresponds to zebrafish MR Leu856, suggesting that progesterone activates lungfish MR.  Frog 
MR has Thr871 at this position, consistent with progesterone being an antagonist for frog MR 
[13].  Unexplained, at this time, is the basis for progesterone activation of chicken MR, which 
has Thr867 at the key position in helix 8.  Thus, progesterone would be expected to inactivate 
chicken MR.  It appears that another mechanism can lead to progesterone activation of chicken 
MR. 
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Progesterone, a physiological ligand for cartilaginous fish and ray-finned fish MRs. 
Because aldosterone is not synthesized by ray-finned fish, other corticosteroids: cortisol, 
11-deoxycorticosterone and corticosterone, have been proposed as physiological ligands for fish 
MRs [15, 67-71].  We proposed that progesterone also is a candidate activator of fish MR due to 
its low EC50 for MRs in zebrafish, gar and sturgeon [12, 16].  Moreover, synthesis of 
progesterone is simpler than 11-deoxycorticosterone (21-hydroxy-progesterone) and cortisol 
(Figure 5) providing a parsimonious model for the hypothesis that progesterone is a 
physiological ligand for ray-finned fish and cartilaginous fish MRs, although 11-
deoxycorticosterone and other corticosteroids also may activate fish MRs. 
We also note that progesterone lacks an 11β-hydroxyl, and thus progesterone is inert to 
11β-hydroxysteroid dehydrogenase-type 2 (11β-HSD2).  Fish contain 11β-HSD2 [28, 72, 73], 
which regulates access of cortisol to the MR [7, 27, 28, 35, 72-74].  Thus, like aldosterone and 
11-deoxycorticosterone, progesterone can occupy the MR in the presence of 11β-HSD2, an 
enzyme that can act as gatekeeper to exclude cortisol and corticosterone from the MR. 
 
 
Figure 5.  Pathway for Synthesis of Adrenal Steroids from Progesterone.  
Cortisol is synthesized from progesterone in three steps. 
 
Unexplored functions of progesterone activation of cartilaginous fish and ray-finned fish 
MRs. 
Progesterone activation of fish MR indicates that progesterone has two functions in ray-
finned fishes.  One function, of course, is progesterone’s classical activity as a reproductive 
hormone [75-77].  A second unexplored function is the physiology of progesterone activation of 
fish MR, which is expressed in diverse tissues in cichlids [78] and trout [15], including ovary a 
reproductive tissue in which progesterone also activates the PR.  Moreover, analysis of gene 
 10 
 
transcription using RNA-Seq reveals that the MR in elephant shark is expressed in many tissues 
[12], including brain, heart, lung and liver, ovary and testis, as well as kidney and colon, the two 
“traditional” tissues for MR physiology.  Little is known of the function progesterone activation 
of the MR in ovary, testis or other tissues in ray-finned fish or elephant shark. 
Studies of corticosteroid activation of the MR in zebrafish [79-83] and medaka [70, 71, 
84, 85] are beginning to elucidate the role of the MR in extra-renal tissues.  We suggest parallel 
studies in zebrafish and medaka to investigate progesterone activation of the MR in heart, brain, 
lung, kidney, gill, liver, ovary, testis and other organs that contain an MR.  For example, analysis 
of gene transcription using RNA-Seq of these organs in zebrafish exposed to progesterone, 
cortisol, 11-deoxycorticosterone and aldosterone should provide important insights into 
similarities and differences in gene expression due to these steroids. 
The discovery by Fuller et al. [52] that zebrafish Thr856 MR is not activated by 
progesterone provides a neat protocol for studying the role of progesterone activation of 
zebrafish MR.  CRISPR [86, 87] could selectively insert Thr856 into zebrafish MR in brain, 
heart, ovary, testis, kidney, gill, etc. to provide tissues in which the MR is not activated by 
progesterone, but can still be activated by circulating cortisol and deoxycorticosterone.  This 
approach provides an opportunity to elucidate the role of progesterone in zebrafish, and it may 
uncover novel physiological functions for the MR in ray-finned fish, which are only beginning to 
be understood [71, 79-85] .  Unexpectedly, although the MR is expressed in kidney and gill, the 
MR does not appear to regulate sodium uptake, the classical “mineralocorticoid function”, in 
fish.  Instead, the GR, activated by cortisol, regulates sodium uptake in zebrafish [88, 89], 
indicating that the MR has other functions in fish kidney and gill. 
 
Unexplored functions of progesterone in human MR 
The physiological consequences of progesterone acting as an antagonist of human MR 
are poorly understood [36, 49, 90-92].  An important advance in appreciating the physiological 
relevance of circulating levels of progesterone on human MR comes from Geller et al,’s [9] 
discovery of a human MR Ser810Leu mutation that is activated by progesterone.  Geller et al [9, 
93] found that a 15-year old male with MR Ser810Leu had high blood pressure (210/120 mmHg) 
due to sodium reabsorption mediated by progesterone activation of this mutant MR, indicating 
that physiological levels of progesterone in males are sufficient to activate this mutant MR.  As 
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expected, females with Leu810 MR also have high blood pressure.  Considering the nM affinity 
of progesterone for human MR and progesterone’s inertness to 11β-HSD2, progesterone would 
be expected to occupy wild-type MR in tissues expressing 11β-HSD2 [28, 29, 35, 38, 41, 94, 
95]. 
Cortisol has been proposed to activate human MR in tissues that lack 11β-HSD2.  A role 
for progesterone in competing with cortisol for binding to the MR in these tissues needs to be 
investigated. 
 
Progesterone activation of chicken MR. 
Progesterone activation of chicken MR was unexpected [12, 13] because chicken MR, 
Thr667 corresponds to Thr670 in human MR, which should mean that chicken MR is not 
activated by progesterone.  The mutation(s) that confer progesterone activation of chicken MR 
are unknown.  The protocol used by Fuller et al. [52] to decipher the basis for progesterone 
activation of zebrafish MR should work to decipher progesterone activation of chicken MR. 
The use of RNA-Seq analysis proposed for studying progesterone activation of zebrafish 
MR also can be used to elucidate the function of progesterone activation of chicken MR in brain, 
heart, lung, thyroid, liver, kidney, spleen, stomach, pancreas, and pituitary [96].  RNA-Seq 
analysis of these tissues from chickens exposed to progesterone and aldosterone should provide 
insights into similarities and differences in gene expression due to these steroids. 
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